Medical News

RSS

Graceway Pharmaceuticals acquires global rights to Gilead Sciences' GS 9191 anti-proliferative agent

Graceway Pharmaceuticals, LLC, a portfolio company of GTCR Golder Rauner, LLC, today announced that the company has acquired from Gilead Sciences, Inc. the worldwide license, including related regulatory filings and intellectual properties, to Gilead’s investigational molecule, GS 9191, for topical use. GS 9191 is an anti-proliferative agent that works by inhibiting cellular DNA synthesis, leading to the induction of apoptosis, or programmed cell death.

7 Nov 2009

With clocking ticking toward Saturday, House leaders continue push for health reform votes

The Associated Press: "Voting is set for Saturday on the 10-year, $1.2 trillion legislation that embraces Obama's goals of extending health coverage to tens of millions of uninsured Americans and putting tough new restrictions on insurance companies." The points of contention remain abortion and immigration (Werner, 11/6).

7 Nov 2009

Illegal flavored cigarettes: FDA issues warning letters to companies selling them

The U.S. Food and Drug Administration is enforcing the flavored cigarette ban provision of the Family Smoking Prevention and Tobacco Control Act (Tobacco Control Act) by issuing several warning letters to companies continuing to sell illegal flavored cigarettes to consumers in the United States through their Web sites.

7 Nov 2009

Student health plans in Massachusetts blasted by report

"Insurance companies rack up much higher profits on health coverage sold to nearly 100,000 Massachusetts college students than on plans available to the general public, according to long-awaited data released late yesterday by the state," The Boston Globe reports.

7 Nov 2009

Genetix Pharmaceuticals develops a gene therapy product to treat ALD

Genetix Pharmaceuticals, a leader in gene therapy of somatic stem cells, announced today the company’s clinical program to treat Adrenoleukodystrophy (ALD). The company is developing a gene therapy product in collaboration with Professor Patrick Aubourg and Doctor Nathalie Cartier of the National Institute of Health and Medical Research (INSERM).

7 Nov 2009

Third quarter 2009 financial results announced by SCOLR Pharma

SCOLR Pharma, Inc. (Amex: DDD) today reported financial results for the three and nine months ended September 30, 2009.

7 Nov 2009

Obama to meet with House Democrats Saturday

President Barack Obama's meeting with House Democrats - originally scheduled for today - is now slated for tomorrow, in advance of an expected weekend vote on the health reform bill.

7 Nov 2009

NIH grants $1 million to study whether Transcendental Meditation can prevent future heart attacks in CHD patients

The National Institutes of Health's National Heart, Lung, and Blood Institute will fund a $1 million collaborative study by the Center for Natural Medicine and Prevention at Maharishi University of Management Research Institute and Columbia University Medical Center to determine whether the stress-reducing Transcendental Meditation technique can help patients with coronary heart disease (CHD) prevent future heart attacks, strokes and death.

7 Nov 2009

CCEC relocates to a new place

Central California Endoscopy Center is proud to announce it has moved into its new, larger facility. Central California Endoscopy Center (CCEC) is now located at 7055 N. Fresno Street, in Suite 100 Fresno, CA 93720. We began to serve patients November 5, 2009.

6 Nov 2009

GeoVax Labs announces financial results and operational update for the third quarter of 2009

GeoVax Labs, Inc., an Atlanta-based, biopharmaceutical company developing human vaccines for diseases caused by HIV-1 (Human Immunodeficiency Virus) and other infectious agents, today announced its third quarter 2009 financial results and provided an operational update.

6 Nov 2009

Results of Areopedic product brings a 74% gross margin with an average order of over $450 dollars

Dynamic Response Group, Inc. announced today preliminary results for the Areopedic product. The results brought a 74% gross margin with an average order of over $450 dollars.

6 Nov 2009

Rights group highlights maternal health issues in India

"India is falling behind other countries in meeting international commitments to improve obstetric care because it does not adequately monitor deaths and injuries in the critical period following childbirth and fix gaps in its health system and programmes," Human Rights Watch said Wednesday, the Hindu reports.

6 Nov 2009

Senate Democrats' leaders face challenges, plot strategy on health reform bill

The Wall Street Journal reports on Sen. Mary Landrieu, D-La., who says she generally supports the health overhaul efforts, but would like to see more items like higher federal Medicaid payments for her state, increased coverage for foster children and more help for teaching hospitals in Louisiana before she commits to voting for the bill — all while insisting Democrats lower the cost of the bill."

6 Nov 2009

Boston Scientific reaches agreement with DOJ related to product advisories issued by its Guidant subsidiary

Boston Scientific Corporation (NYSE: BSX) today announced that it has reached an agreement in principle with the U.S. Department of Justice (DOJ) related to product advisories issued by its Guidant subsidiary in 2005. The alleged conduct and product sales occurred prior to Boston Scientific's 2006 acquisition of Guidant.

6 Nov 2009

Calbiotech awarded a SBIR contract to develop analyte specific reagents for the diagnosis of Dengue virus

Calbiotech, Inc. announced today that it has been awarded a Small Business Innovative Research (SBIR) Phase I contract by the U.S. Army Medical Research and Material command. Under terms of the agreement, Calbiotech will develop analyte specific reagents (ASRs) for the diagnosis of Dengue virus.

6 Nov 2009

GTC Biotherapeutics announces financial results for third quarter 2009

GTC Biotherapeutics, Inc.’s total net loss for the third quarter ended September 27, 2009 was $5.1 million, or $0.48 per share, compared with $6.1 million, or $0.59 per share, in the third quarter of 2008. The total net loss for the first nine months of 2009 was $26.2 million, or $2.51 per share, compared to $16.5 million, or $1.71 per share, for the first nine months of 2008.

6 Nov 2009

Inscrybe Healthcare to be included in CPR+ Integrated Solutions Provider program

Authentidate Holding Corp., a worldwide provider of secure Health Information Exchange and workflow management services, has introduced an interface that allows Inscrybe® Healthcare to be easily integrated with one of the homecare industry's leading information systems, Definitive Homecare Solutions' CPR+(TM).

6 Nov 2009

PPMD awards $75,000 grant to University of California professor for Duchenne muscular dystrophy research

Patricia A. Furlong, Founding President and CEO of Parent Project Muscular Dystrophy (PPMD), the largest non-profit organization in the United States focused on finding a cure for Duchenne muscular dystrophy (Duchenne), announced today the latest recipient of the End Duchenne Grant Award Program.

6 Nov 2009

Swine flu vaccine distribution to New York companies causes uproar

The distribution of swine flu vaccines to big name companies in New York has caused an uproar as people complain that children and health care workers should receive top priority. The New York Times reports: "New York City health officials have distributed small amounts of the swine flu vaccine to some major New York companies, including Wall Street banks like Goldman Sachs and Citigroup, even as shortages continue.

6 Nov 2009

Publications examine U.S. funding for global HIV/AIDS

In light of a Medecins Sans Frontieres (MSF) report calling for sustained HIV/AIDS funding, VOA News writes: "Many AIDS-related groups and activists have been calling on U.S. President Barack Obama to fulfill his funding pledges made during the presidential campaign. But are they asking too much, considering the economic downturn?" Sharonann Lynch, an HIV policy advisor for MSF, said, "PEPFAR has the opportunity to save six million lives and it shouldn't settle for three."

6 Nov 2009

Medical News

Graceway Pharmaceuticals acquires global rights to Gilead Sciences' GS 9191 anti-proliferative agent

With clocking ticking toward Saturday, House leaders continue push for health reform votes

Illegal flavored cigarettes: FDA issues warning letters to companies selling them

Student health plans in Massachusetts blasted by report

Genetix Pharmaceuticals develops a gene therapy product to treat ALD

Third quarter 2009 financial results announced by SCOLR Pharma

Obama to meet with House Democrats Saturday

NIH grants $1 million to study whether Transcendental Meditation can prevent future heart attacks in CHD patients

CCEC relocates to a new place

GeoVax Labs announces financial results and operational update for the third quarter of 2009

Results of Areopedic product brings a 74% gross margin with an average order of over $450 dollars

Rights group highlights maternal health issues in India

Senate Democrats' leaders face challenges, plot strategy on health reform bill

Boston Scientific reaches agreement with DOJ related to product advisories issued by its Guidant subsidiary

Calbiotech awarded a SBIR contract to develop analyte specific reagents for the diagnosis of Dengue virus

GTC Biotherapeutics announces financial results for third quarter 2009

Inscrybe Healthcare to be included in CPR+ Integrated Solutions Provider program

PPMD awards $75,000 grant to University of California professor for Duchenne muscular dystrophy research

Swine flu vaccine distribution to New York companies causes uproar

Publications examine U.S. funding for global HIV/AIDS

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Latest News